BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 18674735)

  • 1. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of primary sclerosing cholangitis among first-degree relatives.
    Bergquist A; Lindberg G; Saarinen S; Broomé U
    J Hepatol; 2005 Feb; 42(2):252-6. PubMed ID: 15664252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
    Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.
    Kaplan GG; Laupland KB; Butzner D; Urbanski SJ; Lee SS
    Am J Gastroenterol; 2007 May; 102(5):1042-9. PubMed ID: 17313496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
    Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
    Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
    Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O; Schrumpf E; Elgjo K
    Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease.
    Orholm M; Fonager K; Sørensen HT
    Am J Gastroenterol; 1999 Nov; 94(11):3236-8. PubMed ID: 10566721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
    Marchesa P; Lashner BA; Lavery IC; Milsom J; Hull TL; Strong SA; Church JM; Navarro G; Fazio VW
    Am J Gastroenterol; 1997 Aug; 92(8):1285-8. PubMed ID: 9260790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
    Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
    J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.